Web31 mar 2024 · The current study aims to evaluate whether prophylactic anticoagulation using argatroban or an increased dose of unfractionated heparin (UFH) is effective in achieving the targeted activated partial thromboplastin time (aPTT) of more than 45 s in critically ill heparin-resistant (HR) patients. Patients were randomized either to continue receiving an … WebArgatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. [2] In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in ...
Argatra Inf Konz 250 mg 2,5ml - Compendium.ch
WebARGATRA Inf Konz 250 mg/2.5ml (Argatroban): Antikoagulans, direkter Thrombininhibitor, monovalent; Durchstechflasche 2.5 ml: Liste B WebDescription. Set of calibration plasmas for argatroban (Argatra ®, Arganova ®, or Novastan ®), measurements, titrated and optimised using the anti-IIa clotting assay HEMOCLOT Thrombin Inhibitors (ref. CK002K/CK002L).. Intended use. Calibrating the assays of argatroban using clotting anti-IIa methods, especially when the HEMOCLOT Thrombin … eagle via outer layer diameter
Wichtige Mitteilung über ein Arzneimittel Argatroban 1 mg/ml
WebIn this clinical trial, we sought to investigate whether anticoagulation using argatroban (Argatra ®, Mitsubishi Tanabe Pharma GmbH, Düsseldorf, Germany) or an increased dose of UFH is effective in achieving the targeted activated partial thromboplastin time (aPTT) of more than 45 s in critically ill heparin-resistant patients within a reasonable time period. WebSpitalpharmazie, Telefon: 062 838 5369; Hämatologie, Telefon: 062 838 60 50 Erstellt: K. Keijzers (Spitalpharmazie) Freigegeben: Dr. med. M. Heizmann Name (INN/Brand) … WebPDR Drug Summaries are concise point-of-care prescribing, dosing and administering information to help phsyicans more efficiently and accurately prescribe in their practice PDR's drug summaries are available free of charge and serve as a great resource for US based MDs, DOs, NPs and PAs in patient practice eagle view 1099 filing